A couple of months in the past, celeb Kim Kardashian promoted a prescription morning illness drug, Diclegis. The pharmaceutical firm accountable promptly obtained in hassle for violating america’ federal drug promotion laws.
So far as the Meals and Drug Administration (FDA) was involved, the issue was not the promotion itself, however that Kardashian uncared for to say the drug’s doable uncomfortable side effects, resembling drowsiness. Nor had she mentioned that Diclegis was not permitted for sure girls with extreme and extended vomiting.
The FDA would have discovered the promotion acceptable if the warnings had been included. The advert would have